HELIX DIAGNOSTICS
Comprehensive Pharmacogenomics (PGx) Panel
Panel Description
Many medications are impacted by specific variations in known genes. These genetic variations can contribute to medication efficacy and risk for side effects. Pharmacogenomic testing to guide prescribing, paired with clinical monitoring can impact outcomes for patients by reducing the time to therapeutic effect and reducing the risk of side effects.
This test evaluates a patient’s metabolizer status for 26 genes, which can aid in appropriate medication selection and dosing to reduce risk of side effects and treatment failure for cancer, cardiovascular disease, pain, mental health and other conditions.
Genes Tested (26)
Scroll down for more
Important Panel Information
Turnaround time: 7-10 days
Preferred specimen: BD Vacutainer Whole Blood K2 EDTA Collection Tube 4mL or Oragene Dx Saliva Collection Kit
Shipping Instructions: Specimens to arrive at Helix within 96 hours of collection at ambient temperature.
Patients for whom medication from the following list are being considered, have been ineffective, or caused side effects: Abacavir, Allopurinol, Amikacin, Amitriptyline, Amphetamine, Aripiprazole, Atomoxetine, Atorvastatin, Azathioprine, Brexpiprazole, Brivaracetam, Capecitabine, Carbamazepine, Celecoxib, Citalopram, Clobazam, Clomipramine, Clopidogrel, Clozapine, Codeine, Desipramine, Deutetrabenazine, Dexlansoprazole, Doxepin, Escitalopram, Flecainide, Flibanserin, Fluorouracil, Flurbiprofen, Fluvastatin, Fluvoxamine, Gefitinib, Gentamicin, Haloperidol, Hydrocodone, Ibuprofen, Iloperidone, Imipramine, Kanamycin, Lamotrigine, Lansoprazole, Lofexidine, Lornoxicam, Lovastatin, Meloxicam, Mercaptopurine, Metoprolol, Nortriptyline, Oliceridine, Omeprazole, Ondansetron, Oxcarbazepine, Pantoprazole, Paroxetine, Peginterferon alfa-2a, Peginterferon alfa-2b, Pimozide, Piroxicam, Pitavastatin, Plazomicin, Pravastatin, Propafenone, Quetiapine, Risperidone, Rosuvastatin, Sertraline, Simvastatin, Streptomycin, Tacrolimus, Tamoxifen, Tegafur, Tenoxicam, Thioguanine, Thioridazine, Tobramycin, Tramadol, Trimipramine, Tropisetron, Valbenazine, Venlafaxine, Voriconazole, Vortioxetine, and Warfarin
All detected variants are evaluated according to the Clinical Pharmacogenetics Implementation Consortium (CPIC). Variants are classified based on known, predicted, or possible impact on drug metabolism.